Literature DB >> 7292212

Infection with Chlamydia trachomatis, Mycoplasma hominis and Neisseria gonorrhoeae in patients with acute pelvic inflammatory disease.

B R Møller, P A Mårdh, S Ahrons, E Nüssler.   

Abstract

Of 166 women with acute pelvic inflammatory disease, Mycoplasma hominis was isolated from the cervix of 91 (54.8%), Chlamydia trachomatis was isolated from 37 (22.3%), and Neisseria gonorrhoeae was isolated from nine (5.4%). Of the 91 women from whom M. hominis was recovered, 39 developed a significant change in titer of serum antibodies to the organism within one month after admission. Of the 85 patients from whose cervix M. hominis was not isolated, 11 displayed a significant change in titer of antibody to the organism. A change in the titer of IgG antibodies to C. trachomatis was found in 20 women (54.1%) who had Chlamydia-positive cultures and in 14 (10.9%) whose cultures were negative for Chlamydia. The results of the cultural and serologic studies suggest that M. hominis was associated with pelvic inflammatory disease in approximately one-third of the patients, or in half of those women from whose cervix the organism was isolated. In approximately every fifth woman studied, C. trachomatis seemed to be associated with the pelvic inflammation.

Entities:  

Mesh:

Year:  1981        PMID: 7292212

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  11 in total

1.  Consequences of incomplete antibacterial treatment for chlamydial pelvic inflammatory disease.

Authors:  M J Rosenberg; M S Waugh
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 2.  Mycoplasma hominis - a neglected human pathogen.

Authors:  P A Mårdh
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

3.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911

Review 4.  Tubo-ovarian abscess: pathogenesis and management.

Authors:  N G Osborne
Journal:  J Natl Med Assoc       Date:  1986-10       Impact factor: 1.798

5.  Is pelvic inflammatory disease an indication for treatment with ciprofloxacin?

Authors:  D Hägele; V Chyský
Journal:  Infection       Date:  1988       Impact factor: 3.553

6.  Infections with Neisseria gonorrhoeae and Chlamydia trachomatis in women with acute salpingitis.

Authors:  G B Kristensen; A C Bollerup; K Lind; P A Mårdh; P Ladehoff; S Larsen; A Marushak; P Rasmussen; J Rolschau; I Skoven
Journal:  Genitourin Med       Date:  1985-06

7.  Measurement of antibody to Ureaplasma urealyticum by an enzyme-linked immunosorbent assay and detection of antibody responses in patients with nongonococcal urethritis.

Authors:  M B Brown; G H Cassell; D Taylor-Robinson; M C Shepard
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

8.  Trends in Pelvic Inflammatory Disease Among American Indian and Alaska Native Women, Indian Health Service, 2001-2015.

Authors:  Andria Apostolou; Christina Chapman; Marissa Person; Kristen Kreisel; Jeffrey McCollum
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

Review 9.  Mycoplasmal PID: a review of natural and experimental infections.

Authors:  P A Mårdh
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec

10.  Doxycycline or ofloxacin for outpatient chlamydial pelvic inflammatory disease? A cost-benefit and cost-effectiveness analysis.

Authors:  M J Rosenberg; M S Waugh
Journal:  Infect Dis Obstet Gynecol       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.